We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.

CEO Kevin Conroy Presents Cologuard Commercial Launch Update at 2014 Baird Healthcare Conference

In one of his latest investor conference appearance, Exact Sciences CEO Kevin Conroy delivered the company's presentation at the 2014 Baird Healthcare Conference September 4, 2014.

Conroy discussed Exact Sciences' plans following FDA's approval of Cologuard®, Exact Sciences' first-of-its-kind, noninvasive colon cancer screening test that patients can use at home.

You can view Conroy's slides below, and listen to his presentation on the Baird website.

Topics: Investor Relations

Subscribe To The Blog